{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:40:05Z","timestamp":1784864405248,"version":"3.55.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2000,9,26]]},"DOI":"10.1212\/wnl.55.6.805","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:48:33Z","timestamp":1336916913000},"page":"805-810","source":"Crossref","is-referenced-by-count":88,"title":["A 1-year controlled trial of acetyl-\n            <scp>l<\/scp>\n            -carnitine in early-onset AD"],"prefix":"10.1212","volume":"55","author":[{"given":"L.J.","family":"Thal","sequence":"first","affiliation":[{"name":"From the Department of Neurosciences, University of California\u2013San Diego School of Medicine, La Jolla, and San Diego Veterans Affairs Medical Center, (Dr. Thal) San Diego, CA; Sigma-Tau Pharmaceuticals, Inc., (Drs. Calvani and Amato) Gaithersburg, MD; and Worldwide Clinical Trials, (Dr. Carta) London, England."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Calvani","sequence":"additional","affiliation":[{"name":"From the Department of Neurosciences, University of California\u2013San Diego School of Medicine, La Jolla, and San Diego Veterans Affairs Medical Center, (Dr. Thal) San Diego, CA; Sigma-Tau Pharmaceuticals, Inc., (Drs. Calvani and Amato) Gaithersburg, MD; and Worldwide Clinical Trials, (Dr. Carta) London, England."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Amato","sequence":"additional","affiliation":[{"name":"From the Department of Neurosciences, University of California\u2013San Diego School of Medicine, La Jolla, and San Diego Veterans Affairs Medical Center, (Dr. Thal) San Diego, CA; Sigma-Tau Pharmaceuticals, Inc., (Drs. Calvani and Amato) Gaithersburg, MD; and Worldwide Clinical Trials, (Dr. Carta) London, England."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Carta","sequence":"additional","affiliation":[{"name":"From the Department of Neurosciences, University of California\u2013San Diego School of Medicine, La Jolla, and San Diego Veterans Affairs Medical Center, (Dr. Thal) San Diego, CA; Sigma-Tau Pharmaceuticals, Inc., (Drs. Calvani and Amato) Gaithersburg, MD; and Worldwide Clinical Trials, (Dr. Carta) London, England."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1976.00500040001001"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.2307\/3350099"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410190502"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.7.1215"},{"key":"e_1_3_2_6_2","first-page":"458","volume":"24","year":"1988","unstructured":"Kramer-Ginsberg E, Mohs RC, Aryan M, et al. Clinical predictors of course for Alzheimer patients in a longitudinal study: a preliminary report. Psychopharmacol Bull . 1988; 24: 458\u2013462.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_2_7_2","first-page":"384","volume":"34","year":"1988","unstructured":"Katzman R, Brown T, Thal LJ, et al. Comparison of rate of annual change of mental status scores in four independent studies of patients with Alzheimer\u2019s disease. Ann Neurol . 1988; 34: 384\u2013389.","journal-title":"Ann Neurol"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(92)90074-D"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300410"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410410106"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj0960777"},{"key":"e_1_3_2_12_2","unstructured":"Pande   SV Notel   H Murthy   MSR.   Characteristics of function of and deficiency of carnitine acetylcarnitine translocase.  In:  Borum  PR ed.  Clinical aspects of human carnitine deficiency.   New York:   Pergamon Press 1986:  165\u2013180."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00964865"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00973749"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90255-A"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00966590"},{"key":"e_1_3_2_17_2","first-page":"639.","volume":"18","year":"1992","unstructured":"Tacredi V, Lo Giudice P, D\u2019Arcangelo G, Siniscalchi A, Pacifici L, Ramacci MT. Levocarnitine acetyl affects synaptic transmission in aged rats. Soc Neurosci . 1992; 18: 639.","journal-title":"Soc Neurosci"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(87)90137-7"},{"key":"e_1_3_2_19_2","first-page":"221.","volume":"9","year":"1991","unstructured":"Taglialatela G, Angelucci L, Ramacci MT, Werrbach-Perez K, Jackson GR, Perez-Polo JR. Acetyl-l-carnitine enhances the response of PC12 cells to nerve growth factor. Dev Brain Res . 1991; 9: 221.","journal-title":"Dev Brain Res"},{"key":"e_1_3_2_20_2","first-page":"776.","volume":"18","year":"1992","unstructured":"Taglialatela G, Navarra D, Cruciana R, Ramacci MT, Angelucci L. Treatment with acetyl-l-carnitine (ALCAR) elevates NGF levels in the CNS of aged rats. Soc Neurosci . 1992; 18: 776.","journal-title":"Soc Neurosci"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(92)90451-7"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.11.1726"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(95)80001-8"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.3.705"},{"key":"e_1_3_2_25_2","unstructured":"American Psychiatric Association.  Diagnostic and Statistical Manual of Mental Disorders.   4th ed.   Washington DC:   American Psychiatric Association Press 1994."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.7.939"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410070516"},{"key":"e_1_3_2_29_2","first-page":"1356","volume":"14","year":"1984","unstructured":"Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer\u2019s disease. Am J Psychiatry . 1984; 14: 1356\u20131364.","journal-title":"Am J Psychiatry"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.140.6.566"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/9.3_Part_1.179"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","unstructured":"Guy W ed. Clinical global impressions. In: ECDEU assessment manual for psychopharmacology. DHEW publication no. (ADM) 76-338. rev. ed. Rockville: Department of Health Education and Welfare 1976:218\u2013222.","DOI":"10.1037\/e591322011-001"},{"key":"e_1_3_2_33_2","unstructured":"Armitage P Berry G. Statistical methods in medical research. 2nd ed. Oxford: Blackwell Scientific 1987:205\u2013209 375\u2013378."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1967.10500925"},{"key":"e_1_3_2_35_2","first-page":"531","volume":"24","year":"1988","unstructured":"Yesavage JA, Poulsen SL, Sheikh J, Tanke E. Rates of change of common measures of impairment in senile dementia of the Alzheimer\u2019s type. Psychopharmacol Bull . 1988; 24: 531\u2013534.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.3.390"},{"key":"e_1_3_2_37_2","first-page":"75","volume":"10","year":"1990","unstructured":"Passeri M, Cucinotta D, Bonati PA, Iannuccelli M, Parnetti L, Senin U. Acetyl-l-carnitine in the treatment of mildly demented elderly patients. Int J Clin Pharmacol Res . 1990; 10: 75\u201379.","journal-title":"Int J Clin Pharmacol Res"},{"key":"e_1_3_2_38_2","unstructured":"Calvani   M Carta   A.   Acetyl- l -carnitine: its role in neuronal metabolism.  In:  Khachaturian  ZS Blass  JP eds.  Alzheimer\u2019s disease\u2014new treatment strategies.   New York:   Marcel Dekker 1992:  223\u2013228."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00967446"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.55.6.805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T16:04:11Z","timestamp":1711555451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.55.6.805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9,26]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,9,26]]}},"alternative-id":["10.1212\/WNL.55.6.805"],"URL":"https:\/\/doi.org\/10.1212\/wnl.55.6.805","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9,26]]}}}